SCHEMBL1066271

SCHEMBL1066271

[CH2][C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1330514 1.00
SCHEMBL1009207 1.00
SCHEMBL3930 1.00
SCHEMBL27732473 0.95
SCHEMBL4594260 0.86
SCHEMBL1033934 0.74
SCHEMBL502813 0.73
SCHEMBL1586286 0.73
SCHEMBL95768 0.70
SCHEMBL9407095 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235756-A1 COMPOUNDS FOR THE TREATMENT OF HIV THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2023-12-07 WO claimed
WO-2023083884-A1 STABILIZERS BASED ON SYRINGIC ACID, VANILLIC ACID, ISOVANILLIC ACID OR 5-HYDROXYVERATRIC ACID, PLASTIC COMPOSITION, METHOD FOR STABILIZING A PLASTIC COMPOSITION AND STABILIZER COMPOSITION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-05-19 WO claimed
CN-109863146-B Biaryl compounds as immunomodulators 百时美施贵宝公司 2023-02-28 CN claimed
CN-108174603-B 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators 阿芮纳制药有限公司 2021-07-02 CN claimed
EP-3292114-B1 1-HETEROARYL-INDOLINE-4-CARBOXAMIDES AS MODULATORS OF GPR52 USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2020-03-11 EP claimed
CN-109863146-A Aryl-linking compound as immunomodulator 百时美施贵宝公司 2019-06-07 CN claimed
CN-108174603-A 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators for the treatment or prevention of disorders related thereto 阿芮纳制药有限公司 2018-06-15 CN claimed
EP-2958928-B1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma AG (DE) 2018-03-28 EP claimed
CN-105008382-B Estra-1, 3,5(10), 16-tetraene-3-carboxamides for the inhibition of 17 β -hydroxysteroid dehydrogenase (AKR 1C 3) 拜耳医药股份公司 2018-01-30 CN claimed
US-9782391-B2 Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors DR. REDDY'S LABORATORIES LTD. (IN) 2017-10-10 US claimed
US-20050049288-A1 5-MEMBERED HETEROCYCLE-BASED p38 KINASE INHIBITORS MEREO BIOPHARMA 1 LIMINTED (GB) 2005-03-03 US claimed
WO-2005009973-A1 5-MEMBERED HETEROCYCLE-BASED P38 KINASE INHIBITORS NOVARTIS AG (CH) 2005-02-03 WO claimed
EP-1499577-A1 2-(2,6-DICHLOROPHENYL)-DIARYLIMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2005-01-26 EP claimed
US-6790852-B2 HETEROCYCLIC NITROGEN COMPOUNDS SUCH AS 2-(2,6-DICHLOROPHENYL) -4-(3-BROMOPHENYL)-5-(2-(3- HYDROXYPROPYLAMINO)PYRIMIDIN-4-YL) -N-H-IMIDAZOLE, USED AS TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC OR ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2004-09-14 US claimed
US-20030199691-A1 2-(2,6-dichlorophenyl)-diarylimidazoles F. HOFFMANN-LA ROCHE AG (CH) 2003-10-23 US claimed
WO-2003087026-A1 2-(2,6-DICHLOROPHENYL)-DIARYLIMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2003-10-23 WO claimed
EP-0946590-A2 DIHYDROXYPROPYL CYSTEINE PEPTIDE AND AGENT CONTAINING THIS PEPTIDE Gesellschaft für biotechnologische Forschung mbH (GBF) (DE) 1999-10-06 EP claimed
WO-1998027110-A2 DIHYDROXYPROPYL CYSTEINE PEPTIDE AND AGENT CONTAINING THIS PEPTIDE GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) (DE) 1998-06-25 WO claimed
US-5541159-A PEPTIDE HORMONE ANTAGONIST SANDOZ LTD. (CH) 1996-07-30 US claimed
WO-1989009786-A1 PEPTIDE DERIVATIVES SANDOZ AG (CH) 1989-10-19 WO claimed